Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesFisher & Paykel Healthcare Corporation Ltd

Fisher & Paykel Healthcare Corporation Ltd

Healthcare Medical Instruments & Supplies
PortfolioPortfolio WatchlistWatchlist
Company price
39.2 AUD 0.31 ( 0.80%)
Last update at 2026-11-06T06:17:00Z
VOLUME
422723
Market Cap
22877.64M
P/E
55.56

Momentum Score

…

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
38.49
Low
39.23
High
52 Week Price Range
26.28
Low
40.15
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Fisher & Paykel Healthcare designs and manufactures non-invasive respiratory care devices and related consumables for hospital and homecare settings. Long-term growth may be supported by aging populations, rising chronic respiratory disease prevalence and expansion of home-based therapies, while consumables provide recurring revenue that could support predictability. The company appears positioned in a specialized niche with technology-led products that may appeal to investors seeking exposure to medical-device demand.
Key risks include regulatory and reimbursement changes, competition from larger medtech firms, and supply-chain or currency disruptions that could pressure margins and growth.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
38.89
Dividend Yield
1.39%
Revenue TTM
2308.40M
Revenue Per Share
3.93
Gross Profit TTM
1470.10M
Debt / Equity
0.07
ROE
23.39%
Net Debt
-317.29M
ROCE
28.31%
Diluted EPS TTM
0.70

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Income before tax 636.10M 503.30M 235.70M 328.00M 504.20M
Net income 471.91M 377.20M 132.60M 250.30M 376.90M
Selling general administrative - 534.40M 492.80M 431.90M 393.10M
Selling and marketing expenses - 534.40M 492.80M 431.90M 393.10M
Gross profit 1511.63M 530.20M 1044.40M 945.90M 1013.40M
Reconciled depreciation - 139.90M 114.30M 99.00M 96.00M
Ebit 671.86M 514.40M 353.40M 334.70M 509.10M
Ebitda 831.61M 654.30M 444.80M 433.70M 605.10M
Depreciation and amortization 159.75M 139.90M 91.40M 99.00M 96.00M
Operating income 671.86M -371.00M 353.40M 310.80M 468.28M
Other operating expenses 1684.17M 1651.30M 1389.40M 34.05M 76.69M
Interest expense 10.37M 11.10M 18.20M 6.70M 4.90M
Tax provision - 126.10M 103.10M 77.70M 127.30M
Interest income - 4.30M 3.30M 2.60M 2.60M
Net interest income - -6.80M -14.90M -4.10M -2.30M
Income tax expense 164.19M 126.10M 103.10M 77.70M 127.30M
Total revenue 2356.03M 1280.30M 1742.80M 1588.60M 1642.40M
Total operating expenses 839.77M 901.20M 691.00M 705.20M 643.10M
Cost of revenue 844.40M 750.10M 698.40M 642.70M 629.00M
Total other income expense net -35.76M 874.30M -117.70M -7.60M 40.20M
Net income from continuing ops - 377.20M 132.60M 250.30M 376.90M
Net income applicable to common shares - - - 250.30M 376.90M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Total assets 2874.38M 2550.80M 2281.70M 2204.50M 2107.00M
Intangible assets 73.23M 82.10M 88.40M 85.60M 86.80M
Other current assets 21.15M - 45.30M 68.90M 64.70M
Total liab 743.57M 660.40M 522.60M 451.10M 427.30M
Total stockholder equity 2130.80M 1890.40M 1759.10M 1753.40M 1679.70M
Other current liab 411.27M - 256.40M 230.90M 231.64M
Common stock 501.53M - 404.00M 303.70M 261.20M
Capital stock - 468.60M 404.00M 303.70M 261.20M
Retained earnings 1453.31M 1226.60M 1095.00M 1200.50M 1181.20M
Other liab - - - 36.80M 36.10M
Other assets - - - 196.20M 174.40M
Cash 464.46M 264.50M 82.00M 121.00M 89.90M
Total current liabilities 501.42M 500.40M 385.00M 289.80M 303.90M
Current deferred revenue - - - -5.40M 1.46M
Net debt -317.29M - 107.10M 24.80M 14.40M
Short term debt 33.04M - 96.20M 21.30M 17.00M
Short long term debt - 64.00M 78.50M 4.20M 5.30M
Short long term debt total 147.16M - 189.10M 145.80M 104.30M
Other stockholder equity -5.24M - - -1407.29M -1335.93M
Property plant equipment - - - 1148.20M 957.80M
Total current assets 1160.59M 935.40M 704.90M 774.20M 887.90M
Net tangible assets - - - 1667.80M 1592.90M
Short term investments - - - 0.47M 200.00M
Net receivables 345.30M 267.30M 257.20M 218.50M 174.40M
Long term debt - - 35.70M 79.10M 63.00M
Inventory 329.68M 342.90M 320.40M 365.80M 358.90M
Accounts payable 57.11M 52.90M 32.40M 43.00M 53.80M
Accumulated other comprehensive income 181.21M - 260.10M 249.20M 237.30M
Non currrent assets other - - 55.90M 99.62M 90.81M
Non current assets total 1713.79M 1615.40M 1576.80M 1430.30M 1219.10M
Capital lease obligations - 89.30M 74.90M 62.50M 36.00M
Breakdown 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2026-03-31 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Investments - -103.00M -339.00M -11.30M 80.30M
Change to liabilities - - - -19.00M -5.70M
Total cashflows from investing activities -196.62M -103.00M -339.00M -11.30M -89.50M
Net borrowings - -56.90M 30.60M -4.40M -14.10M
Total cash from financing activities -278.71M -268.20M -128.70M -197.10M -235.80M
Net income 471.91M 377.20M 132.60M 234.17M 349.08M
Change in cash 173.44M 179.30M -35.90M 32.20M -0.80M
Begin period cash flow 291.02M 80.90M 116.80M 84.60M 85.40M
End period cash flow 464.46M 260.20M 80.90M 116.80M 84.60M
Total cash from operating activities 668.03M 548.60M 429.60M 222.85M 300.36M
Issuance of capital stock - 3.10M 3.00M 3.00M 3.20M
Depreciation 159.75M - 109.10M 87.85M 80.30M
Other cashflows from investing activities - -29.40M -22.20M - -
Dividends paid 254.14M -195.90M -145.50M -195.70M -224.90M
Change to inventory 15.61M -22.50M 45.40M -6.46M -81.78M
Change to account receivables -28.61M -45.10M -38.50M -40.51M 48.62M
Sale purchase of stock - - - 137.50M 7.50M
Other cashflows from financing activities -21.56M -18.50M -16.80M -14.40M -14.00M
Change to netincome - - - -41.90M -107.10M
Capital expenditures 174.06M 103.00M 339.00M 211.30M 169.80M
Change in working capital 16.12M -67.60M 6.90M -46.97M -33.16M
Stock based compensation - - 10.80M 8.42M 7.50M
Other non cash items 24.07M 616.20M 170.20M -99.17M -129.02M
Free cash flow 493.97M 445.60M 90.60M 11.55M 130.56M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
FPH
Fisher & Paykel Healthcare Corporation Ltd		 0.31
0.80%		 39.20 55.56 48.54 9.91 12.92 11.78 33.96
RMD
Resmed Inc		 0.14
0.40%		 34.75 21.77 19.57 8.49 5.53 5.50 14.10
ANN
Ansell Ltd		 0.14
0.31%		 45.66 21.27 22.73 2.99 2.16 2.24 12.03
NAN
Nanosonics Ltd		 -0.06
2.03%		 2.89 49.17 78.12 4.33 4.02 3.64 24.30
AHC
Austco Healthcare Ltd		 -0.01
3.64%		 0.27 13.75 16.31 1.09 1.63 0.94 5.71

Profile*

Fisher & Paykel Healthcare Corporation Ltd

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

15 Maurice Paykel Place, Auckland, New Zealand, 2013

64 9 574 0100

https://www.fphcare.com

7357

Name Title Year Born
Mr. Lewis G. Gradon MD, CEO & Exec. Director 1961
Ms. Lyndal York Chief Financial Officer NA
Dr. Andrew Somervell VP of Products & Technology NA
Hayden Brown Investor Relations Mang. NA
Karen Knott Gen. Mang. of Corp. Communications NA
Mr. Paul N. Shearer B.Com. Sr. VP of Sales & Marketing NA
Ms. Nicola Talbot VP of HR NA
Mr. Jonathan Rhodes VP of Supply Chain, Facilities & Sustainability NA
Mr. Marcus Driller VP of Corp. & Company Sec. NA
Chris Crone Gen. Mang. of Airvo Optiflow NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…